Ro-24-0238

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRo-24-0238
Drug Alias NameRO-240238Ro-24-0238
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsPlatelet activating factor receptor antagonists
TargetsThromboxane A2 synthasePlatelet activating factor receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A